Hepatitis B surface antigen (HBsAg) prevalence (%) in Ethiopia
Ethiopia: Hepatitis B surface antigen (HBsAg) prevalence was 0.6% in 2024. ▼ Falling
Latest (2024)
0.6%
Change on year
unchanged
World rank
51st
of 194 countries
All-time high
1.5%
in 2015
All-time low
0.6%
in 2023
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Ethiopia, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for hepatitis b surface antigen (hbsag) prevalence in Ethiopia is 0.6%, measured in 2024. That is the lowest value across all 10 years on record.
That represents a change of down 60.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Ethiopia peaked at 1.5% in 2015 and was at its lowest, 0.6%, in 2023.
That places Ethiopia 51st out of 194 countries with data for 2024, putting it in the middle of the range.
Hepatitis B surface antigen (HBsAg) prevalence in Ethiopia, year by year
| Year | Value | Change |
|---|---|---|
| 2015 | 1.5% | — |
| 2016 | 1.3% | -13.3% |
| 2017 | 1.2% | -7.7% |
| 2018 | 1.0% | -16.7% |
| 2019 | 0.9% | -10.0% |
| 2020 | 0.7% | -22.2% |
| 2021 | 0.7% | +0.0% |
| 2022 | 0.7% | +0.0% |
| 2023 | 0.6% | -14.3% |
| 2024 | 0.6% | +0.0% |
Ethiopia compared with similar countries
- Ethiopia's 0.6% is below the median for low income countries, which is 0.7%, 86% of the median. (25 countries reporting)
- Ethiopia's 0.6% is below the median for Sub-Saharan Africa, which is 1.1%, 57% of the median. (48 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 1.2% | 0.9% | 1.5% | 5 |
| 2020s | 0.7% | 0.6% | 0.7% | 5 |
Countries ranked near Ethiopia
- 51 Tonga 0.6% compare
- 51 Cote d'Ivoire 0.6% compare
- 51 Micronesia (country) 0.6% compare
- 51 Laos 0.6% compare
- 51 Madagascar 0.6% compare
- 51 Nauru 0.6% compare
- 51 Palau 0.6% compare
More health data for Ethiopia
- Un projection of annual infant deaths, annual growth rate -1.67 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.9494 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 744.3 deaths per 1,000 people (2090)
- Number of infants who die before age 1 19,997 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 148 (2025)
- Population ages 00-04, female, annual growth rate 1.34 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0.0001 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0709 units per person (2025)
- Population ages 00-04, male, annual growth rate 1.36 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0.0001 units per US$ of GDP (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Ethiopia?
- Hepatitis b surface antigen (hbsag) prevalence in Ethiopia was 0.6% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Ethiopia?
- The highest recorded value was 1.5% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Ethiopia?
- The lowest recorded value was 0.6% in 2023.
- How does Ethiopia rank for hepatitis b surface antigen (hbsag) prevalence?
- Ethiopia ranks 51st out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Ethiopia?
- Over the last ten years it is down 60.0%. The long-run trend across the full record is falling.
- Where does this Ethiopia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).